Efficacy and tolerability of alirocumab in Austrian clinical practice – results of the non-interventional PEARL-AT study

The present data indicate a good overall efficacy of alirocumab in a real-world Austrian population. Effectiveness and safety were both in line with the clinical trial program as well as previous real-world observations.